[Dr.Vad]

Studies have shown that the problem ceases when PPI therapy is discontinued or replaced by the use of an H2‐receptor antagonist 4, 11, but treatment of ID in situations in which continued PPI therapy is required has been poorly studied. Intravenous iron therapy should be avoided. Over a decade, we have found (unpublished observations) that, in most cases, daily administration of low oral doses of iron, at a meal preceded by 250–500 mg vitamin C and not following ingestion of a PPI, is usually effective.

[Ссылки доступны только зарегистрированным пользователям ]